N-(3-acyloxy-2-benzylpropyl)-N′-dihydroxytetrahydrobenzazepine and tetrahydroisoquinoline thiourea analogues as vanilloid receptor ligands
The vanilloid receptor represents a promising target for drug development. Building on our previous strategies which have generated potent agonists for VR1, we now describe a series of novel N-(3-acyloxy-2-benzylpropyl)-N′-dihydroxytetrahydrobenzazepine a
Lee, Jeewoo,Lee, Jiyoun,Szabo, Tamas,Gonzalez, Adamar F.,Welter, Jacqueline D.,Blumberg, Peter M.